Read more about the article FDA Roundup: July 23, 2024

FDA Roundup: July 23, 2024

  • Post author:
  • Post category:

For Immediate Release: July 23, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating tablet approved for the prevention of pregnancy. Norethindrone acetate and ethinyl estradiol, the main ingredients in

Continue ReadingFDA Roundup: July 23, 2024
Read more about the article FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

  • Post author:
  • Post category:

For Immediate Release: July 16, 2024 Español Today, the U.S. Food and Drug Administration and the Federal Trade Commission (FTC) issued warning letters to five companies for illegally selling copycat food products containing delta-8 THC and introducing them into the marketplace in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The warning

Continue ReadingFDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

  • Post author:
  • Post category:

Enforcement We enforce federal competition and consumer protection laws that prevent anticompetitive, deceptive, and unfair business practices. View Enforcement ,Search or browse the Legal Library Find legal resources and guidance…

Continue ReadingFTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’

CADE and South Center discuss competition and patent protection in the pharmaceutical sector during seminar

  • Post author:
  • Post category:

O Conselho Administrativo de Defesa Econômica (Cade) e a organização intergovernamental South Centre realizaram, nesta sexta-feira (18/08), o Observatório da Concorrência. O seminário teve como objetivo discutir regulação, concorrência e…

Continue ReadingCADE and South Center discuss competition and patent protection in the pharmaceutical sector during seminar